Why Complete Dose Availability Matters for Your Success
Complete Wegovy or Mounjaro Dose Range: Your Treatment Journey Simplified
When comparing Wegovy or Mounjaro, one critical factor often overlooked is dose availability throughout your treatment. Both medications require careful dose escalation over 16 weeks, progressing from 0.25mg starter doses to 2.4mg maintenance therapy. EverydayMeds maintains complete inventory of all five doses for both treatments, eliminating the frustration of switching pharmacies mid-journey. This comprehensive approach ensures continuity of care whether your prescriber recommends semaglutide (Wegovy) or tirzepatide (Mounjaro).
Our complete dose strategy recognises that successful weight management requires consistent access to prescribed medications. Many patients report anxiety about dose transitions, particularly when moving from 1.7mg to the crucial 2.4mg maintenance dose. By stocking every dose strength, we remove this barrier and allow you to focus on your health goals rather than pharmacy logistics. This reliability becomes especially important during the 17+ week maintenance phase, where consistent 2.4mg supply is essential for sustained results.
Wegovy or Mounjaro Pricing: Transparent Costs Across All Doses
Understanding the complete cost structure when choosing between Wegovy or Mounjaro helps you budget for your entire treatment journey. Our single pen prices reflect the dose escalation schedule: 0.25mg starter pens cost £79.99, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for maintenance 2.4mg pens. New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices.
Our bundle options provide convenient multi-dose packages for smoother treatment transitions. The Intro Trio bundle (0.25mg, 0.5mg, and 1mg) costs £299.99, covering your first 12 weeks of treatment. For maintenance therapy, our Ultimate Stability Trio provides three months of 2.4mg pens for £649.99, ensuring uninterrupted supply during the critical long-term phase. These bundles eliminate the need for frequent reordering while guaranteeing dose availability.
Clinical Evidence: How Wegovy or Mounjaro Perform in Trials
When evaluating Wegovy or Mounjaro options, clinical trial data provides valuable insights into their effectiveness. In the STEP 1 trial, patients taking Wegovy alongside a reduced-calorie diet and increased physical activity experienced an average weight reduction of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained results with 15.2% average weight loss maintained at 2 years.
Mounjaro's clinical program showed comparable effectiveness in weight management studies, though direct head-to-head comparisons between Wegovy or Mounjaro aren't available due to different trial designs and populations. Both treatments demonstrated their effectiveness specifically at the 2.4mg maintenance dose, highlighting why access to this dose strength is crucial for optimal outcomes. Your prescriber can help determine which option aligns best with your medical profile and treatment goals.
How These Weight Management Medications Work
Understanding the mechanism behind Wegovy or Mounjaro helps explain why consistent dosing matters for success. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural hormones controlling appetite and food intake. It works by slowing gastric emptying, promoting satiety after smaller meals, and reducing food cravings through effects on brain appetite centres. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors, potentially offering dual hormonal pathways for appetite regulation. Both medications are designed to support weight management when used alongside lifestyle modifications, not as standalone solutions.
Streamlined Ordering Process for Wegovy or Mounjaro
Accessing either Wegovy or Mounjaro through EverydayMeds follows our straightforward three-step process designed for both convenience and clinical safety. Complete our 3-minute online clinical assessment, providing relevant medical history and current medications for prescriber review. Our qualified prescribers typically review applications within 3 working days (express 24-hour review available), ensuring thorough evaluation of your suitability for treatment. Once approved, we dispatch your prescription-only medicine via next-day delivery using temperature-controlled packaging that maintains the 2-8°C cold-chain requirements throughout transit.
Storage and Practical Considerations: Wegovy or Mounjaro Handling
Proper storage significantly impacts medication effectiveness, making this an important factor when choosing between Wegovy or Mounjaro options. Both treatments require refrigeration at 2-8°C before first use, but Wegovy offers superior room temperature stability—up to 6 weeks below 30°C once removed from the fridge, compared to Mounjaro's 21-day limit. This storage advantage makes Wegovy particularly suitable for frequent travellers or those with limited refrigerator space. Both medications use pre-filled FlexTouch injection pens for once-weekly administration, with dose escalation occurring every 4 weeks according to the prescribed schedule. Never skip doses or accelerate the escalation timeline, as this increases the risk of gastrointestinal side effects.
Lifetime Supply Partnership: Your Complete Wegovy or Mounjaro Journey
The decision between Wegovy or Mounjaro extends far beyond initial prescription—it's a long-term commitment requiring consistent pharmaceutical support. EverydayMeds positions itself as your treatment partner from first 0.25mg dose through years of 2.4mg maintenance therapy. Our comprehensive stock management ensures you never face treatment interruptions due to supply shortages, a common concern with weight management medications experiencing high demand.
This lifetime value proposition becomes particularly relevant when considering treatment duration. Clinical data suggests that discontinuing treatment often leads to weight regain, with STEP trial participants regaining approximately two-thirds of lost weight within one year of stopping. Our complete dose availability supports long-term treatment adherence by eliminating supply-related barriers that might otherwise compromise your success.
Start Your Weight Management Journey Today
Whether you choose Wegovy or Mounjaro, EverydayMeds provides the complete infrastructure for successful treatment outcomes. New customers can begin with discount code FIRST40 applied at checkout, while existing customers use DOSE25 for continued savings. Our GPhC-registered pharmacy (#9012878) ensures regulatory compliance and pharmaceutical quality throughout your treatment journey. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and access the UK's most comprehensive weight management medication service. Remember that both treatments are prescription-only medicines requiring professional medical oversight alongside your commitment to dietary and exercise modifications.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
